Walmart Statement on the Sale of Ranitidine Products

BENTONVILLE, Ark., Oct. 2, 2019 — Walmart Inc. is suspending the sale of all over the counter ranitidine products in stores, clubs and online, including Zantac, Equate and Member’s Mark brands.

The company is taking this action after closely monitoring the recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level of nitrosodimethylamine (NDMA). Customers who purchased these products may return them to Walmart or Sam’s Club for a refund.

Additional details on NDMA in ranitidine are available through the FDA.

About Walmart
Walmart Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere - in retail stores, online, and through their mobile devices. Each week, over 275 million customers and members visit our more than 11,300 stores under 58 banners in 27 countries and eCommerce websites. With fiscal year 2019 revenue of $514.4 billion, Walmart employs over 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting http://corporate.walmart.com, on Facebook at http://facebook.com/walmart and on Twitter at http://twitter.com/walmart.